

Drug Discovery 3.0: The Age of Designed Biology
We’re back with the second session of Deeptech Futures, a new monthly series sponsored by AlbionVC and hosted by UCL Engineering and IDEALondon (powered by WilbeLAB).
In honour of London Life Sciences Week, this month we’re diving into Drug Discovery 3.0: The Age of Designed Biology. Join us for a forward-looking panel discussion exploring the next frontier in therapeutic innovation.
From cutting-edge technologies like organ-on-a-chip to the rise of personalised medicine, our expert panel will explore how science and technology are converging to accelerate discovery and open doors to therapies once thought impossible.
We invite all founders, operators, researchers, academics, investors and ecosystem builders to join us.
Agenda
5:30 pm — Arrival, refreshments & networking
6:00 pm — Drug Discovery 3.0 – The Age of Designed Biology
6:45 pm — Audience Q&A
7:15 pm — Networking with drinks & snacks provided
8:00 pm — Close
🎤 Speakers:
Nicolas Szita - Professor of Bioprocess Microfluidics and Founder and Managing Director of Young Owl Microfluidics
Patrizia Ferretti - Professor of Regenerative Biology at UCL Institute of Child Health
Tanel Ozdemir - Investment Director at AlbionVC
Debesh Mandal - Co-Founder and CEO at Nanograb
Moderator: Dr Rob Thompson, Vice-Dean (Enterprise), UCL Engineering
About the series
Deeptech Futures: Conversations at the edge of what’s possible is a monthly series from UCL Engineering, sponsored by AlbionVC, that puts leading academics, pioneering founders, and visionary investors in the same room to explore how breakthrough technologies will reshape the way we live, and the opportunities they’ll create.
About UCL Engineering
With ten departments crossing a whole world of activity - from cybersecurity to biofuels, and synthetic tissues to international trade - UCL Engineering is one of the most diverse Engineering schools in Europe.
About IDEALondon
IDEALondon is UCL Engineering’s home for ambitious founders in the heart of Shoreditch, run by WilbeLAB. We bring together startups in AI, biotech, fintech, climate, and more, giving founders workspace and community.